Literature DB >> 30942930

Quantitative muscle ultrasound in upper extremity mononeuropathies.

Yun Wang1,2, Hilda Gutierrez2, Maria Martucci2, Alison Poussaint1,2, Kristin Qi2, Benjamin Sanchez2, Seward B Rutkove2.   

Abstract

INTRODUCTION: We assessed the potential use of quantitative ultrasound (QUS) in the evaluation hand muscles affected by upper extremity mononeuropathies.
METHODS: The gray scale levels (GSLs) of abductor pollicis brevis (APB), abductor digiti minimi (ADM), and first dorsal interosseous (FDI) of 30 healthy and 30 upper extremity mononeuropathy patients were measured and compared with standard electrophysiological values.
RESULTS: Mean GSL was elevated in 34 APBs of carpal tunnel syndrome patients and 18 FDIs of ulnar neuropathy patients (e.g., FDI mean GSL (interquartile range) 31.5 (27.3~43.8) arbitrary units for patients and 24.0(23.0~29.0) for healthy subjects (P = 0.020)). GSL correlated with motor response amplitudes (Spearman's rho (ρ) = -0.39, P = 0.002 in APB, ρ = -0.72, P = 0.002 in FDI, and ρ = -0.43, P = 0.013 in ADM). The APB GSL correlated with electromyographic severity and disease duration (ρ = 0.46, P < 0.001 and ρ = 0.45, P = 0.003).
CONCLUSIONS: Muscle QUS may serve as a useful tool in upper extremity mononeuropathy evaluation. Further study of this concept is recommended.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  electromyography; gray scale level; hand muscle; nerve conduction; quantitative ultrasound; upper extremity mononeuropathies

Mesh:

Year:  2019        PMID: 30942930      PMCID: PMC6579675          DOI: 10.1002/mus.26481

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  28 in total

1.  Three ulnar nerve conduction studies in patients with ulnar neuropathy at the elbow.

Authors:  M J Kothari; M Heistand; S B Rutkove
Journal:  Arch Phys Med Rehabil       Date:  1998-01       Impact factor: 3.966

2.  Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity.

Authors:  Antonella Di Pasquale; Stefania Morino; Simona Loreti; Elisabetta Bucci; Nicola Vanacore; Giovanni Antonini
Journal:  Neurology       Date:  2015-01-28       Impact factor: 9.910

3.  Correlating ultrasound findings of carpal tunnel syndrome with nerve conduction studies.

Authors:  Jae Min Kim; Min Wook Kim; Young Jin Ko
Journal:  Muscle Nerve       Date:  2013-09-11       Impact factor: 3.217

Review 4.  Peripheral tumor and tumor-like neurogenic lesions.

Authors:  Evandro Abreu; Sébastien Aubert; Guillaume Wavreille; Ramon Gheno; Clarissa Canella; Anne Cotten
Journal:  Eur J Radiol       Date:  2011-05-10       Impact factor: 3.528

5.  Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy.

Authors:  Craig M Zaidman; Jim S Wu; Kush Kapur; Amy Pasternak; Lavanya Madabusi; Sung Yim; Adam Pacheck; Heather Szelag; Tim Harrington; Basil T Darras; Seward B Rutkove
Journal:  Ann Neurol       Date:  2017-05-04       Impact factor: 10.422

6.  Interrater reliability of the needle examination in lumbosacral radiculopathy.

Authors:  Richard Kendall; Robert A Werner
Journal:  Muscle Nerve       Date:  2006-08       Impact factor: 3.217

7.  Quantitative electromyography in ambulatory boys with Duchenne muscular dystrophy.

Authors:  Sumit Verma; Jenny Lin; Curtis Travers; Courtney McCracken; Durga Shah
Journal:  Muscle Nerve       Date:  2017-05-24       Impact factor: 3.217

8.  Quantitative EMG in inflammatory myopathy.

Authors:  P E Barkhaus; S D Nandedkar; D B Sanders
Journal:  Muscle Nerve       Date:  1990-03       Impact factor: 3.217

Review 9.  Ultrasound of Focal Neuropathies.

Authors:  Lisa D Hobson-Webb; Luca Padua
Journal:  J Clin Neurophysiol       Date:  2016-04       Impact factor: 2.177

10.  Muscle ultrasound analysis: normal values and differentiation between myopathies and neuropathies.

Authors:  Natalia Maria Maurits; Anna Elizabeth Bollen; Alphons Windhausen; Aeiko Eppo Jurjen De Jager; Johannes Harmen Van Der Hoeven
Journal:  Ultrasound Med Biol       Date:  2003-02       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.